Abstract:The incidence and mortality rate of cancer has been quickly increasing in the past decades. At present, cancer has become the leading cause of death worldwide. Most of the cancers cannot be effectively diagnosed at the early stage. Although there are multiple therapeutic treatments, including surgery, radiotherapy, chemotherapy, and targeted drugs, their effectiveness is still limited. The overall survival rate of malignant cancers is still low. It is necessary to further study the mechanisms for malignant cancers, and explore new biomarkers and targets that are more sensitive and effective for early diagnosis, treatment, and prognosis of cancers than traditional biomarkers and methods. Long non-coding RNAs (lncRNAs) are a class of RNA transcripts with a length greater than 200 nucleotides. Generally, lncRNAs are not capable of encoding proteins or peptides. LncRNAs exert diverse biological functions by regulating gene expressions and functions at transcriptional, translational, and post-translational levels. In the past decade, it has been demonstrated that the dysregulated lncRNA profile is widely involved in the pathogenesis of many diseases, including cancer, metabolic disorders, and cardiovascular diseases. In particular, lncRNAs have been revealed to play an important role in tumor growth and metastasis. Many lncRNAs have been shown to be potential biomarkers and targets for the diagnosis and treatment of cancers. This review aims to briefly discuss the latest findings regarding the roles and mechanisms of some important lncRNAs in the pathogenesis of certain malignant cancers, including lung, breast, liver, and colorectal cancers, as well as hematological malignancies and neuroblastoma.

Research progress of the interactions between long non-coding RNAs and miRNAs in human cancer

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Dysregulation Of Long Non-Coding Rna In Breast Cancer: An Overview Of Mechanism And Clinical Implication

Long Noncoding RNA: Its Partners and Their Roles in Cancer

The crucial role of LncRNA MIR210HG involved in the regulation of human cancer and other disease

Post-transcriptional Regulation of Long Noncoding RNAs in Cancer

Unexpected roles of long non-coding RNAs in cancer biology

Research progress of genetic polymorphisms in long non-coding RNAs as tumor biomarkers

The Role of Non-Coding RNA in Tumorigenesis, Development,diagnosis and Treatment

The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment

Mysterious long noncoding RNAs and their relationships to human disease

Emerging role of RNA modification and long noncoding RNA interaction in cancer

The Emerging Role of Major Regulatory RNAs in Cancer Control

Outlook and advances in research on miRNAs in cancer

Noncoding RNAs: Different Roles in Tumorigenesis

miRNA-based biomarkers, therapies, and resistance in Cancer

Long Non-Coding RNA in the Pathogenesis of Cancers

Research progress of long non-coding RNAs in breast carcinomas

Potential Roles of Micrornas in Regulating Long Intergenic Noncoding RNAs

Research Progress on Lung Cancer Related MicroRNAs

Targeting long non-coding RNAs in cancers: progress and prospects